Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc. is a legitimate registered non-Hong Kong company duly registered under Part 16 of the Companies Ordinance (Cap. 622) of Hong Kong on 1971-07-02 (operating for 55 years). According to the official register of the Hong Kong Companies Registry (CR), the entity holds an active statutory status of [Live / In Operation] (Statutory records last verified: September 2026).

Under Hong Kong's Unique Business Identifier (UBI) regime, Shanghai Henlius Biotech, Inc. is identified by two official registration numbers: its 8-digit Business Registration Number (BRN / UBI) [69358933] administered by the Inland Revenue Department, and its 7-digit Company Registration Number (CRN) [F0024357] maintained by the Companies Registry for historical statutory filings.

Pursuant to Sections 627 and 643 of the Hong Kong Companies Ordinance (Cap. 622), the equity ownership and executive board of Shanghai Henlius Biotech, Inc. are governed by its statutory Register of Members and Register of Directors. Any appointment or resignation of directors or the company secretary must be filed within 15 days via Form ND2A, while complete shareholder equity ratios are disclosed annually in Form NAR1. Furthermore, under Section 653H of Cap. 622, the company must maintain a Significant Controllers Register (SCR) for persons holding over 25% beneficial interest or voting rights.

Yes. Official filing registers of the Hong Kong Companies Registry confirm that Shanghai Henlius Biotech, Inc. has statutory filings on official record. Pursuant to Part 16 (Section 788) of the Companies Ordinance (Cap. 622), registered non-Hong Kong companies must deliver an Annual Return (Form NN3) to the Registrar of Companies within 42 days after each registration anniversary. Available verified original dossiers include: latest Annual Return of Non-Hong Kong Company (Form NN3 - detailing principal place of business in Hong Kong and authorised representatives), Application for Registration (Form NN1), Constitutive Documents, and Change of Secretary/Director/Authorised Representative notices (Form NN7 / NN8C), all carrying official ICRIS barcode verification.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Officially licensed by Hong Kong statutory authorities, currently holding: Statutory Authority (Hkex) (Licence No. 02696); 2. Judicial Screening (Litigation & Winding-Up): public court records screening identified 1 public court docket(s) associated with this corporation; confirmed no compulsory winding-up petitions (HCCW) on file. Specific court levels (High Court HCA / District Court DCCJ), case numbers, party capacities, and judgments are accessible via official Due Diligence Reports.

The principal place of business in Hong Kong of Shanghai Henlius Biotech, Inc. on official record is situated at: [ROOM C, 20/F, NATHAN COMMERCIAL BUILDING, 430-436 NATHAN ROAD, YAU TSIM MONG DISTRICT, HONG KONG]. Pursuant to Part 16 (Section 791) of the Companies Ordinance (Cap. 622), all registered non-Hong Kong companies must maintain a principal place of business in Hong Kong and notify the Registrar within 15 days of any change (Form NN9) for the lawful service of statutory notices and court process.

Unlike jurisdictions with government ICP domain licensing, Hong Kong regulates corporate identity disclosure under Section 4 of the Companies (Disclosure of Company Name and Liability Status) Regulation (Cap. 622B): Shanghai Henlius Biotech, Inc. must legibly display its exact registered name on all business letters, contracts, invoices, and any company website, and report its website (if any) in its Annual Return (Form NAR1) or Form NR2. To prevent cross-border impersonation, trade partners should authenticate the company's legal standing via its statutory identifiers (CRN: F0024357 / 8-digit BRN: 69358933) and barcoded Companies Registry dossiers rather than unverified external web pages.